Imatron revenues soar 147%
Ultrafast CT developer Imatron is beginningto experience increased demand for its high-priced CT technology.The South San Francisco, CA, vendor reported last month that revenuesskyrocketed 147% for the second quarter (end-June). Imatron recorded
Ultrafast CT developer Imatron is beginningto experience increased demand for its high-priced CT technology.The South San Francisco, CA, vendor reported last month that revenuesskyrocketed 147% for the second quarter (end-June).
Imatron recorded revenues of $7.9 million for the quarter,a marked improvement over the $3.2 million reported in the sameperiod last year. Income was also up sharply. Imatron recordednet income of $447,000, compared to a net loss of $2.7 millionin the second quarter of 1993.
Imatron shipped four Ultrafast CT scanners during the quarterand achieved several other milestones in its technology developmentprojects, according to president and CEO Lewis Meyer.
Imatron has a CT development agreement with Siemens, whichmarkets the Imatron scanner as Evolution EBT (electron-beam tomography).Imatron also operates HeartScan Imaging, which provides UltrafastCT coronary artery scanning in company-owned clinics (SCAN 4/6/94).
FDA Clears Ultrasound AI Detection for Pleural Effusion and Consolidation
June 18th 2025The 14th FDA-cleared AI software embedded in the Exo Iris ultrasound device reportedly enables automated detection of key pulmonary findings that may facilitate detection of pneumonia and tuberculosis in seconds.
Can Contrast-Enhanced Mammography be a Viable Screening Alternative to Breast MRI?
June 17th 2025While the addition of contrast-enhanced mammography (CEM) to digital breast tomosynthesis (DBT) led to over a 13 percent increase in false positive cases, researchers also noted over double the cancer yield per 1,000 women in comparison to DBT alone.
Ultrasound-Guided Thermal Ablation Shows Low Recurrence of Thyroid Carcinoma at Five Years
June 16th 2025In a meta-analysis involving over 2,200 patients with T1NoMo papillary thyroid carcinoma, researchers noted 2 percent recurrence and no cases of lymph node metastasis five years after ultrasound-guided thermal ablation.
